Clinical symptoms and risk factors in cerebral microangiopathy patients. - Test2 - elhamkhani - TriplyDB

Clinical symptoms and risk factors in cerebral microangiopathy patients.

Clinical symptoms and risk factors in cerebral microangiopathy patients.

http://www.wikidata.org/entity/Q34580847

about

METACOHORTS for the study of vascular disease and its contribution to cognitive decline and neurodegeneration: An initiative of the Joint Programme for Neurodegenerative Disease Research Treatment of Vertigo: A Randomized, Double-Blind Trial Comparing Efficacy and Safety of Ginkgo biloba Extract EGb 761 and Betahistine.Impact of small vessel disease in the brain on gait and balance Small vessel disease and memory loss: what the clinician needs to know to preserve patients' brain health.Aging with Cerebral Small Vessel Disease and Dizziness: The Importance of Undiagnosed Peripheral Vestibular Disorders.White matter lesions reduce number of brain metastases in different cancers: a high-resolution MRI study.

P2860

Q33588283-F87F740E-8B91-4682-8360-A6447C045AD6 Q33904850-52E0BC73-6228-4FEF-BC6E-525E658AC8DF Q37612684-CD94F583-5A2C-463B-94B9-E031F668C0D1 Q38150763-EC68E923-E72B-4086-AC7A-70FD810223FF Q42230364-DD3376E7-B9F7-468F-ABB5-7976A6DC02CE Q48472896-9429C8C2-CA4A-400B-98B9-59FDB43E09F9

P2860

Clinical symptoms and risk factors in cerebral microangiopathy patients.

http://www.wikidata.org/entity/Q34580847

description

2013 nî lūn-bûn

@nan

2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Clinical symptoms and risk factors in cerebral microangiopathy patients.

@ast

Clinical symptoms and risk factors in cerebral microangiopathy patients.

@en

Clinical symptoms and risk factors in cerebral microangiopathy patients.

@nl

type

label

Clinical symptoms and risk factors in cerebral microangiopathy patients.

@ast

Clinical symptoms and risk factors in cerebral microangiopathy patients.

@en

Clinical symptoms and risk factors in cerebral microangiopathy patients.

@nl

prefLabel

Clinical symptoms and risk factors in cerebral microangiopathy patients.

@ast

Clinical symptoms and risk factors in cerebral microangiopathy patients.

@en

Clinical symptoms and risk factors in cerebral microangiopathy patients.

@nl

P1433

Q34580847-0E27DD3F-57F3-4094-8C00-D9D90F3A0014

P1476

Q34580847-6BBE1CD6-C07D-4085-B188-6FED94EE6B10

P2093

Q34580847-057F51B4-7BBC-4EF9-9F62-5EC0C240151D

Q34580847-5C1B8909-CCEB-4BDF-9444-81A2C7243427

Q34580847-6E74B939-259A-4E5E-9BA0-6E17B1054A2E

Q34580847-C80ECA6E-6915-4B33-85A6-FD876684D211

P2860

Q34580847-00A2DB10-2155-4BC8-A2A9-FFE79A6A717E

Q34580847-05F45F76-7396-478A-A262-BDD2863B0E33

Q34580847-0E458CBE-F90C-4FF4-A1F4-F7F0A65D8AB5

Q34580847-1BE3E699-5E45-4FD1-A382-989EC1376F79

Q34580847-1C91D8E6-BAB9-4155-8962-8C21EFCD5A61

Q34580847-1FD8BDC9-744F-49E8-977D-4A5BD9CE0ED0

Q34580847-26C73693-B006-4BE5-B24C-1AF464215473

Q34580847-2B2D7D44-3411-4CC8-96E0-311604B9491D

Q34580847-34C22AD8-4F80-4375-AA4E-E27C7A709C4C

Q34580847-549C51AA-642D-4515-952C-E149BFCB08CB

P304

Q34580847-6AFC27DC-0A2F-40AB-9C51-6594825A6AA5

P31

Q34580847-DDCDA57D-0785-4A22-BCFA-19D3E7A9B5A6

P356

Q34580847-4A6EBFFA-96FF-4707-9349-19920387DF4E

P407

Q34580847-D50CB52D-7020-40F8-A534-BDF04B074050

P433

Q34580847-56604BCE-8BF9-4071-8F00-619B79239C92

P478

Q34580847-C00FFF11-B395-4A18-AA99-04A1A0FB2A80

P50

Q34580847-FD90EC46-3C93-40D1-A33C-1BBE411655D0

P577

Q34580847-B772E3C6-68E3-43FA-AE1B-13C3BB89F6E0

P5875

Q34580847-21B213CE-90D8-4A65-BE9D-317C02BA5342

P698

Q34580847-1BA3DAED-8BB3-4842-AE0E-8C61F6741FEF

P932

Q34580847-9137593F-531F-4FE6-B174-D93E39A8222D

P356

JOURNAL.PONE.0053455

P1433

P1476

Clinical symptoms and risk factors in cerebral microangiopathy patients.

@en

P2093

Catherine N Widmann

http://www.w3.org/2001/XMLSchema#string

Horst Urbach

http://www.w3.org/2001/XMLSchema#string

Michael T Heneka

http://www.w3.org/2001/XMLSchema#string

Sandra Okroglic

http://www.w3.org/2001/XMLSchema#string

P2860

Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges

Central vertigo and dizziness: epidemiology, differential diagnosis, and common causes

Cerebral white matter changes and geriatric syndromes: is there a link?

Epileptic seizures in subcortical vascular encephalopathy.

Type 2 diabetes mellitus, cognitive impairment and dementia.

Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations.

Magnetic resonance imaging in cerebral small vessel disease and its use as a surrogate disease marker.

Homocysteine, silent brain infarcts, and white matter lesions: The Rotterdam Scan Study.

Cognitive and functional impairment in hypertensive brain microangiopathy.

Hyperlipidemia and reduced white matter hyperintensity volume in patients with ischemic stroke

P304

e53455

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0053455

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Philip Scheltens

P577

2013-02-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235423462

http://www.w3.org/2001/XMLSchema#string

P698

23393549

http://www.w3.org/2001/XMLSchema#string

P932

3564848

http://www.w3.org/2001/XMLSchema#string